المؤلفون: Karolína Štěrbová, Lucie Raisová Stuchlíková, Nikola Rychlá, Kateřina Kohoutová, Markéta Babičková, Lenka Skálová, Petra Matoušková

المصدر: International Journal for Parasitology: Drugs and Drug Resistance, Vol 25, Iss , Pp 100555- (2024)

مصطلحات موضوعية: AKR, Haemonchus contortus, Expression profile, Drug-susceptibility, Drug-resistance, Phylogenetic analysis, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2211320724000368; https://doaj.org/toc/2211-3207

URL الوصول: https://doaj.org/article/39672f26764e484c97325a8a1f13294d

المؤلفون: Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett, Arnold G. Vulto

المصدر: Frontiers in Pharmacology, Vol 11 (2021)

مصطلحات موضوعية: adalimumab, prices, biosimilars, Europe, Humira, competition, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2020.591134/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/91efa0738a404ac58954a5cf23bc3c10

المؤلفون: Jan Činčera, Kateřina Kohoutová, Júlia Sokolovičová

المصدر: Envigogika, Vol 5, Iss 3 (2010)

مصطلحات موضوعية: evaluace, kvalitativní výzkum, vzdělávání učitelů, Special aspects of education, LC8-6691, Environmental sciences, GE1-350

وصف الملف: electronic resource

Relation: https://www.envigogika.cuni.cz/index.php/Envigogika/article/view/55; https://doaj.org/toc/1802-3061

URL الوصول: https://doaj.org/article/c0db5d96599b4812b5307774091beee5

المؤلفون: Vasileios Kourafalos, Eleonora Allocati, Luka Voncina, Brian Godman, Arianit Jakupi, Robert Plisko, Evelien Moorkens, Kateřina Kohoutová, Nataša Grubiša, Gisbert Selke, Anita Viksna, Arnold G. Vulto, Jurij Fürst, Jaana E. Martikainen, Leona Popelková, Ileana Mardare, Patricia Vella Bonanno, Vincent Suttorp, Dorthe Bartels, Sarah Mörtenhuber, Ott Laius, Iris Hoxha, Gustaf Befrits, Isabelle Huys, Dmitry Meshkov, Gnosia Achniotou, Rannveig Einarsdóttir, Øyvind Melien, Juraj Slabý, Ieva Greičiūtė-Kuprijanov, Simon Keuerleber, Einar Magnusson, Corinne Zara, Admir Malaj, Robert Puckett, Silvia Stockinger, Vanda Marković-Peković, Maria Dimitrova, Vera Vlahović Palčevski, Konstantin Tachkov, Tanja Novakovic, Roisin Adams, Roberta Joppi

المساهمون: Erasmus MC other, Pharmacy

المصدر: Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, 11:591134. Frontiers Media S.A.
Frontiers in Pharmacology
Volume 11

مصطلحات موضوعية: Leverage (finance), adalimumab, prices, biosimilars, Europe, Humira, competition, health policy, BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Klinička farmakologija s toksikologijom, RS, Competition (economics), adalimumab, Adalimumab, medicine, National Policy, Pharmacology (medical), biosimilars, Humira, Reimbursement, Health policy, Pharmacology, Public economics, lcsh:RM1-950, Biosimilar, health policy, BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Clinical Pharmacology and Toxicology, Product (business), Europe, lcsh:Therapeutics. Pharmacology, Business, competition, prices, medicine.drug

وصف الملف: Electronic-eCollection; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faa4da2fb244fd6ae5a4663168b042ca
https://www.frontiersin.org/articles/10.3389/fphar.2020.591134/full

المؤلفون: Evelien, Moorkens, Brian, Godman, Isabelle, Huys, Iris, Hoxha, Admir, Malaj, Simon, Keuerleber, Silvia, Stockinger, Sarah, Mörtenhuber, Maria, Dimitrova, Konstantin, Tachkov, Luka, Vončina, Vera Vlahović, Palčevski, Gnosia, Achniotou, Juraj, Slabý, Leona, Popelková, Kateřina, Kohoutová, Dorthe, Bartels, Ott, Laius, Jaana E, Martikainen, Gisbert W, Selke, Vasileios, Kourafalos, Einar, Magnússon, Rannveig, Einarsdóttir, Roisín, Adams, Roberta, Joppi, Eleonora, Allocati, Arianit, Jakupi, Anita, Viksna, Ieva, Greičiūtė-Kuprijanov, Patricia, Vella Bonanno, Vincent, Suttorp, Øyvind, Melien, Robert, Plisko, Ileana, Mardare, Dmitry, Meshkov, Tanja, Novakovic, Jurij, Fürst, Corinne, Zara, Vanda, Marković-Peković, Nataša, Grubiša, Gustaf, Befrits, Robert, Puckett, Arnold G, Vulto

المصدر: Frontiers in Pharmacology

مصطلحات موضوعية: Pharmacology, Europe, adalimumab, biosimilars, Humira, health policy, competition, prices, Original Research

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::4d8152979b218c4c2a189561dc041fcd
https://pubmed.ncbi.nlm.nih.gov/33519450

المؤلفون: Evelien Moorkens, Brian Godman, Isabelle Huys, Iris Hoxha, Admir Malaj, Simon Keuerleber, Silvia Stockinger, Sarah Mörtenhuber, Maria Dimitrova, Konstantin Tachkov, Luka Vončina, Vera Vlahović Palčevski, Gnosia Achniotou, Juraj Slabý, Leona Popelková, Kateřina Kohoutová, Dorthe Bartels, Ott Laius, Jaana E. Martikainen, Gisbert W. Selke, Vasileios Kourafalos, Einar Magnússon, Rannveig Einarsdóttir, Roisín Adams, Roberta Joppi, Eleonora Allocati, Arianit Jakupi, Anita Viksna, Ieva Greičiūtė-Kuprijanov, Patricia Vella Bonanno, Vincent Suttorp, Øyvind Melien, Robert Plisko, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Corinne Zara, Vanda Marković-Peković, Nataša Grubiša, Gustaf Befrits, Robert Puckett, Arnold G. Vulto

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, adalimumab, prices, biosimilars, Europe, Humira, competition, health policy

Relation: https://figshare.com/articles/dataset/datasheet1_The_Expiry_of_Humira_Market_Exclusivity_and_the_Entry_of_Adalimumab_Biosimilars_in_Europe_An_Overview_of_Pricing_and_National_Policy_Measures_pdf/13567664

الاتاحة: https://doi.org/10.3389/fphar.2020.591134.s001
https://figshare.com/articles/dataset/datasheet1_The_Expiry_of_Humira_Market_Exclusivity_and_the_Entry_of_Adalimumab_Biosimilars_in_Europe_An_Overview_of_Pricing_and_National_Policy_Measures_pdf/13567664

المؤلفون: Kokaisl, Petr, Bäumelová, Markéta, Bednaříková, Eva, Beneš, Jan, Borecký, Pavel, Bubák, Adam, Cihlářová, Nina, Doležal, Jakub, Felkelová, Klára, Hajas, Lubomír, Hajný, Jakub, Hejduková, Veronika, Herrmannová, Zuzana, Hrušková, Nikola, Ilievová, Veronika, Kartousová, Lucie, Kohlová, Zuzana, Kateřina Kohoutová, Kopal, Petr, Kopeček, Petr, Matiášek, Marek, Mrázová, Renata, Nádvorníková, Iva, Němečková, Radka, Nováková, Dagmar, Alžběta Novotná, Tomáš Obruba, Panská, Pavla, Patočková, Anna, Pětioká, Ida, Pištěková, Martina, Lukáš Policar, Procházková, Jana, Eliška Steklíková, Štolfová, Andrea, Tóthová, Tereza, Vála, David, Židková, Leona

الاتاحة: https://dx.doi.org/10.13140/rg.2.1.3382.1523
http://rgdoi.net/10.13140/RG.2.1.3382.1523